Glenmark Pharmaceuticals informs about board meeting

30 Oct 2024 Evaluate

Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors will be held on Thursday, November 14, 2024, to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2024. Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its directors and other designated persons regarding the closure of trading window from September 30, 2024 to November 16, 2024 for the purpose of approval of Unaudited Financial Results for the second quarter and half year ended September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1465.30 -27.05 (-1.81%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.